Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jupiter Neurosciences Inc...

    NASDAQ: JUNS · Real-Time Price · USD
    1.09
    -0.03 (-2.68%)
    At close: Jun 13, 2025, 3:59 PM
    1.03
    -5.94%
    After-hours: Jun 13, 2025, 07:58 PM EDT

    Jupiter Neurosciences Statistics

    Share Statistics

    Jupiter Neurosciences has 33.1M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 33.1M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 591

    FTD / Avg. Volume

    n/a
    		 0.21%

    Short Selling Information

    The latest short interest is 100.19K, so 0.3% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 100.19K

    Short % of Shares Out

    n/a
    		 0.3%

    Short % of Float

    n/a
    		 0.59%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -126.24 and the forward PE ratio is 10.59. Jupiter Neurosciences's PEG ratio is 2.9.

    PE Ratio

    n/a
    		 -126.24

    Forward PE

    n/a
    		 10.59

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 8.7

    PB Ratio

    n/a
    		 73.82

    P/FCF Ratio

    n/a
    		 -78.75

    PEG Ratio

    n/a
    		 2.9
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Jupiter Neurosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 2.31

    Quick Ratio

    n/a
    		 2.31

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 -0.06

    Interest Coverage

    n/a
    		 -12.45

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-609,906.25

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -0.24, so Jupiter Neurosciences's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.24

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.7

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 56.42

    Average Volume (20 Days)

    n/a
    		 278,420

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -3.09M

    Net Income

    n/a
    		 -2.44M

    EBITDA

    n/a
    		 -2.19M

    EBIT

    n/a
    		 -2.19M

    Earnings Per Share (EPS)

    n/a
    		 -0.08
    Full Income Statement

    Balance Sheet

    The company has 3.77M in cash and 217.76K in debt, giving a net cash position of 3.55M.

    Cash & Cash Equivalents

    n/a
    		 3.77M

    Total Debt

    n/a
    		 217.76K

    Net Cash

    n/a
    		 3.55M

    Retained Earnings

    n/a
    		 -26.02M

    Total Assets

    n/a
    		 4.96M

    Working Capital

    n/a
    		 1.72M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3.91M and capital expenditures 0, giving a free cash flow of -3.91M.

    Operating Cash Flow

    n/a
    		 -3.91M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -3.91M

    FCF Per Share

    n/a
    		 -0.14
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    JUNS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for JUNS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.48

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist